Zobrazeno 1 - 10
of 72
pro vyhledávání: '"van Troostenburg A"'
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany
Autor:
Hoechstetter, Manuela A., Knauf, Wolfgang, Dambacher, Silvia, Hucke, Nike, Höhne, Kristin, van Troostenburg, Anna, Ramroth, Heribert, Abenhardt, Wolfgang, Rummel, Mathias
Publikováno v:
In Clinical Lymphoma, Myeloma and Leukemia August 2022 22(8):e777-e787
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany
Autor:
Manuela A. Hoechstetter, Wolfgang Knauf, Silvia Dambacher, Nike Hucke, Kristin Höhne, Anna van Troostenburg, Heribert Ramroth, Wolfgang Abenhardt, Mathias Rummel
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e777-e787
In pivotal studies, idelalisib demonstrated remarkable efficacy and manageable tolerability in patients with chronic lymphocytic leukemia (CLL) and follicular lymphoma (FL). This prospective, multicenter, non-interventional post-authorization study a
Autor:
Lampertico P., Berg T., Buti M., Pathil A., Petersen J., Ryder S. D., Zoulim F., Botros I., Flaherty J. F., Jump B., Op den Brouw M. L., van Troostenburg A., Ramroth H., Bourliere M., De Ledinghen V., Riachi G., Loustaud-Ratti V., Tran A., Larrey D., Dumortier J., Leroy V., Metivier S., Sellier P., Mauss S., Peterson J., Schiefke I., Niederau C., Teuber G., Goeser T., Jung M. C., Grambihler A., Pathil-Warth A., Sprinzl K., Von der Ohe M., Antoni C., Weigand K., Andreone P., Di Marco V., Madonia S., Puoti M., Santantonio T., Vigano M., Ciancio A., D'Offizi G., Pirisi M., Suarez Garcia E., Pascasio Acevedo J. M., Andrade R., Gea F., Serra Desfilis M. A., Molina Perez E., Manzano Alonso M., Carrion J. A., Aoufi Rabih S., Planas M. M., Ryder S., Agarwal K., Ustianowski A., Aspinall R., Kennedy P., Geretti A. M., McCorry R., Foxton M., Healy B.
Publikováno v:
Alimentary pharmacology & therapeutics
BackgroundLimited data exist regarding tenofovir disoproxil fumarate (TDF) safety and effectiveness in chronic hepatitis B virus-infected (CHB) patients with renal impairment (RI).AimsTo compare real-world data on renal safety and effectiveness of TD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3176cfd9b4d6129fbb96c6246af0e59f
http://hdl.handle.net/10447/509984
http://hdl.handle.net/10447/509984
Autor:
Nishanthan Rajakumaraswamy, S. Kovalchuk, Ruth Pettengell, Gilles Salles, Elisabeth Vandenberghe, Anna van Troostenburg, Susana Carvalho, Annalisa Chiarenza, Ka Lung Wu, Paolo Corradini, Rikisha Shah Gupta, Christophe De Belder, Santiago Mercadal, Heribert Ramroth
Publikováno v:
Blood. 136:48-50
Introduction: Idelalisib, a selective oral inhibitor of PI3Kδ, was approved by the FDA and EMA as monotherapy for patients with advanced follicular lymphoma (FL) based on positive efficacy and safety results from the registration phase 2 trial in pa
Autor:
Salles, Gilles, Wu, Ka Lung, Kovalchuk, Sofya *, Mercadal, Santiago *, Chiarenza, Annalisa *, Pettengell, Ruth *, Vandenberghe, Elisabeth *, Corradini, Paolo *, Carvalho, Susana *, De Belder, Christophe *, Shah Gupta, Rikisha *, van Troostenburg, Anna *, Rajakumaraswamy, Nishanthan *, Ramroth, Heribert *
Publikováno v:
In Blood 5 November 2020 136 Supplement 1:48-50
Autor:
Emmanuel Gyan, Francesco Di Raimondo, Francesco Merli, Anthony Boland, Heribert Ramroth, Rikisha Shah Gupta, Benedetta Puccini, Luca Baldini, Maria Chiara Tisi, Carolyn Dunnill, Anna van Troostenburg, Gilles Salles, Nishanthan Rajakumaraswamy, Santiago Mercadal, Ka Lung Wu, Elisabeth Vandenberghe
Publikováno v:
Blood. 138:1350-1350
Background: Malignant lymphoid cells are characteristically dependent on signals mediated by the phosphatidylinositol 3-kinase delta isoform (PI3Kδ). Idelalisib is an oral, selective, PI3Kδ inhibitor approved by the FDA and EMA as monotherapy for t
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gyan, Emmanuel, Tisi, Maria Chiara, Merli, Francesco, Baldini, Luca, Di Raimondo, Francesco, Mercadal, Santiago, Puccini, Benedetta, Vandenberghe, Elisabeth, Wu, Ka Lung, Boland, Anthony, Shah Gupta, Rikisha, van Troostenburg, Anna, Dunnill, Carolyn, Ramroth, Heribert, Rajakumaraswamy, Nishanthan, Salles, Gilles
Publikováno v:
In Blood 23 November 2021 138 Supplement 1:1350-1350
Publikováno v:
Drug Discovery and Evaluation: Methods in Clinical Pharmacology ISBN: 9783319566375
Drug Discovery and Evaluation: Methods in Clinical Pharmacology
Drug Discovery and Evaluation: Methods in Clinical Pharmacology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b503cbad9cb19a9b89a7947fc9c01df
https://doi.org/10.1007/978-3-319-56637-5_63-1
https://doi.org/10.1007/978-3-319-56637-5_63-1
Autor:
John F. Flaherty, I.L. Rose, I. Faghmous, M. Op Den Brouw, A. Van Troostenburg, C. Phulpin, Heribert Ramroth, Pietro Lampertico
Publikováno v:
Journal of Hepatology. 68:S145-S146